Cargando…
Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes
GM3 is implicated in cell signaling, inflammation and insulin resistance. The intestinal mucosa metabolizes ganglioside and provides gangliosides for uptake by peripheral tissues. Gangliosides downregulate acute and chronic inflammatory signals. It is likely that transport of intestinal derived gang...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775016/ https://www.ncbi.nlm.nih.gov/pubmed/36551897 http://dx.doi.org/10.3390/biomedicines10123141 |
_version_ | 1784855540190412800 |
---|---|
author | Rivas Serna, Irma Magaly Beveridge, Michelle Wilke, Michaelann Ryan, Edmond A. Clandinin, Michael Thomas Mazurak, Vera Christine |
author_facet | Rivas Serna, Irma Magaly Beveridge, Michelle Wilke, Michaelann Ryan, Edmond A. Clandinin, Michael Thomas Mazurak, Vera Christine |
author_sort | Rivas Serna, Irma Magaly |
collection | PubMed |
description | GM3 is implicated in cell signaling, inflammation and insulin resistance. The intestinal mucosa metabolizes ganglioside and provides gangliosides for uptake by peripheral tissues. Gangliosides downregulate acute and chronic inflammatory signals. It is likely that transport of intestinal derived gangliosides to other tissues impact the same signals characteristic of inflammatory change in other chronic conditions such as Type 2 Diabetes (T2DM). The postprandial ceramide composition of GM3 and other gangliosides in plasma and chylomicrons has not been examined in T2DM. The present study assessed if diet or T2DM alters ganglioside components in plasma and chylomicrons secreted from the intestinal mucosa after a meal. GD1, GD3, and GM3 content of chylomicrons and plasma was determined by LC/triple quad MS in non-diabetic (control) and T2DM individuals in the fasting and postprandial state after 2 days of consuming a low or high fat diet in a randomized blinded crossover design. Diet fat level did not alter baseline plasma or chylomicron ganglioside levels. Four hours after the test meal, plasma monounsaturated GD3 was 75% higher, plasma saturated GD3 was 140% higher and plasma polyunsaturated GM3 30% lower in diabetic subjects compared to control subjects. At 4 h, chylomicron GD1 was 50% lower in T2DM compared to controls. The proportion of d34:1 in GD3 was more abundant and d36:1 in GD1 less abundant in T2DM compared to control subjects at 4 h. The present study indicates that T2DM alters ceramide composition of ganglioside available for uptake by peripheral tissues. |
format | Online Article Text |
id | pubmed-9775016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97750162022-12-23 Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes Rivas Serna, Irma Magaly Beveridge, Michelle Wilke, Michaelann Ryan, Edmond A. Clandinin, Michael Thomas Mazurak, Vera Christine Biomedicines Article GM3 is implicated in cell signaling, inflammation and insulin resistance. The intestinal mucosa metabolizes ganglioside and provides gangliosides for uptake by peripheral tissues. Gangliosides downregulate acute and chronic inflammatory signals. It is likely that transport of intestinal derived gangliosides to other tissues impact the same signals characteristic of inflammatory change in other chronic conditions such as Type 2 Diabetes (T2DM). The postprandial ceramide composition of GM3 and other gangliosides in plasma and chylomicrons has not been examined in T2DM. The present study assessed if diet or T2DM alters ganglioside components in plasma and chylomicrons secreted from the intestinal mucosa after a meal. GD1, GD3, and GM3 content of chylomicrons and plasma was determined by LC/triple quad MS in non-diabetic (control) and T2DM individuals in the fasting and postprandial state after 2 days of consuming a low or high fat diet in a randomized blinded crossover design. Diet fat level did not alter baseline plasma or chylomicron ganglioside levels. Four hours after the test meal, plasma monounsaturated GD3 was 75% higher, plasma saturated GD3 was 140% higher and plasma polyunsaturated GM3 30% lower in diabetic subjects compared to control subjects. At 4 h, chylomicron GD1 was 50% lower in T2DM compared to controls. The proportion of d34:1 in GD3 was more abundant and d36:1 in GD1 less abundant in T2DM compared to control subjects at 4 h. The present study indicates that T2DM alters ceramide composition of ganglioside available for uptake by peripheral tissues. MDPI 2022-12-06 /pmc/articles/PMC9775016/ /pubmed/36551897 http://dx.doi.org/10.3390/biomedicines10123141 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rivas Serna, Irma Magaly Beveridge, Michelle Wilke, Michaelann Ryan, Edmond A. Clandinin, Michael Thomas Mazurak, Vera Christine Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes |
title | Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes |
title_full | Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes |
title_fullStr | Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes |
title_full_unstemmed | Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes |
title_short | Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes |
title_sort | interorgan metabolism of ganglioside is altered in type 2 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775016/ https://www.ncbi.nlm.nih.gov/pubmed/36551897 http://dx.doi.org/10.3390/biomedicines10123141 |
work_keys_str_mv | AT rivassernairmamagaly interorganmetabolismofgangliosideisalteredintype2diabetes AT beveridgemichelle interorganmetabolismofgangliosideisalteredintype2diabetes AT wilkemichaelann interorganmetabolismofgangliosideisalteredintype2diabetes AT ryanedmonda interorganmetabolismofgangliosideisalteredintype2diabetes AT clandininmichaelthomas interorganmetabolismofgangliosideisalteredintype2diabetes AT mazurakverachristine interorganmetabolismofgangliosideisalteredintype2diabetes |